We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 625

TCPA Healthcare Companies Seek Ruling on Joint Petition Filed in 2016
  • Klein Moynihan Turco LLP
  • USA
  • August 31 2018

Last week, a group of healthcare companies sent a letter to the Federal Communications Commission (“FCC”) seeking clarification regarding how

Nine Days and Counting - The Fate of CHIP Remains Uncertain Amid Congressional Deadlock
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • October 9 2017

While congressional Republicans spent much of September pushing for passage of the Graham-Cassidy “repeal and replace” bill, other time-sensitive

Disproportionate Share Hospitals Facing Steep Payment Cuts
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • September 28 2017

While September 30, 2017 has been an important procedural deadline for purposes of the GOP’s most recent legislative push to repeal the Affordable

SCOTUS to review health care reform
  • Faegre Baker Daniels LLP
  • USA
  • November 17 2011

As expected, the Supreme Court has agreed to rule on the constitutionality of key provisions of the Affordable Care Act.

Supreme Court to decide constitutionality of health care reform
  • Seyfarth Shaw LLP
  • USA
  • November 14 2011

This is the twenty-ninth issue in our health care reform series of alerts for employers on selected topics in health care reform.

CMS issues first annual report on the permanent Medicare RAC program
  • King & Spalding LLP
  • USA
  • October 10 2011

The Centers for Medicare and Medicaid Services (CMS) recently issued a report to Congress on the permanent Medicare Parts A and B Recovery Audit Contractor (AB RAC) program in fiscal year (FY) 2010 (the Report).

Part D plan mid-year formulary changes reviewed by GAO
  • Reed Smith LLP
  • USA
  • August 16 2011

The GAO has sent a letter to Congress describing how CMS monitors Medicare Part D prescription drug plan sponsors' compliance with mid-year formulary change requirements

Quality of care cases under the False Claims Act: pointers for the defense (Part III of III)
  • Kelley Drye & Warren LLP
  • USA
  • February 18 2011

This is our final post on United States ex rel. Blundell v. Dialysis Clinic, Inc., No. 5:09-cv-00710 (N.D.N.Y. Jan. 19, 2011), a qui tam action against a dialysis treatment center based on alleged quality of care issues that was recently dismissed pursuant to Rules 9(b) and 12(b)(6).

Senators join House colleagues in clarifying intent of biosimilars law
  • Shook Hardy & Bacon LLP
  • USA
  • January 27 2011

Democratic and Republican senators have echoed their House colleagues in a letter to the Food and Drug Administration (FDA), indicating that Congress intended, in enacting the Biologics Price Competition and Innovation Act, that the exclusivity to be accorded innovations under its terms refers to data exclusivity and not market exclusivity for innovator products.

Three-day payment window clarified
  • Baker & Hostetler LLP
  • USA
  • July 8 2010

On June 25, 2010, President Obama signed the Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010.